促性腺激素释放激素激动剂治疗人绒毛膜促性腺激素触发体外受精周期中黄体期缺陷:匹配病例对照研究
研究纳入50例首次IVF失败且黄体期血清孕酮异常低的女性,后续周期分两组匹配比较。组1(25例)在取卵日起每日注射GnRH激动剂共14天,组2(25例)不用GnRH激动剂。组1第二次周期取卵后14天孕酮显著高于第一次(P<0.001),12例(48%)获临床妊娠并分娩;组2两次周期无显著差异。结论认为GnRH激动剂可提高血清孕酮并改善妊娠分娩机会。
要点
- 首次IVF失败且黄体期孕酮低者,再次周期加用GnRH激动剂可提高取卵后14天孕酮(P<0.001)。
- 组1中12例(48%)获临床妊娠并分娩。
- 组2两次周期妊娠结局与血清孕酮无显著差异。
核心结论
- 在黄体期缺陷患者中,胚胎移植后给予GnRH激动剂可提高血清孕酮浓度并改善妊娠与分娩机会。
研究设计与样本
- 匹配病例对照研究,50例首次IVF失败且黄体期血清孕酮异常低的女性在后续周期分为两组,每组25例。
- 组1在第二次IVF周期取卵日起每日注射GnRH激动剂共14天,组2第二次周期胚胎移植后不用GnRH激动剂。
- 两组均比较两次序贯周期取卵后14天血清孕酮浓度与妊娠结局。
主要发现
- 组1第二次周期取卵后14天孕酮显著高于第一次周期(P<0.001)。
- 组1中12例(48%)获临床妊娠并分娩。
- 组2第一次与第二次周期之间妊娠结局及血清孕酮浓度无显著差异。
临床怎么用
- 作者结论认为,对黄体期缺陷患者,胚胎移植后给予GnRH激动剂可提高血清孕酮浓度并改善妊娠与分娩机会。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: This study aimed to identify women with IVF failure associated with low serum progesterone levels after embryo transfer in HCG-triggered cycles and to evaluate the effects of gonadotrophin-releasing hormone (GnRH) agonist, administered after embryo transfer, on serum progesterone and pregnancy outcomes in these cases. DESIGN: Fifty women who failed to achieve an ongoing clinical pregnancy and had abnormally low luteal-phase serum progesterone concentrations in their first IVF attempt were assigned to two matched groups in their subsequent attempt. Twenty-five women were treated with the original protocol plus14 daily injections of GnRH agonist, beginning on the day of oocyte recovery, in their second IVF attempt (group 1). These women were matched to 25 women with the same characteristics and outcomes in their first IVF attempt who underwent the second IVF attempt without the use of GnRH agonist after embryo transfer (group 2). In both groups, the two sequential attempts were compared for serum progesterone concentration 14 days after oocyte recovery and pregnancy outcome. RESULTS: The patients in group 1 had significantly higher progesterone levels 14 days after oocyte recovery in the second attempt compared with the first attempt (P < 0.001), and 12 (48%) of them achieved clinical pregnancy and birth. No significant differences in pregnancy outcome or in the serum progesterone concentration were observed between the first and the second attempt in group 2. CONCLUSIONS: In patients with luteal phase deficiency, the administration of GnRH agonist after embryo transfer increases serum progesterone concentration and improves the chance of pregnancy and birth.
引用
- Mendoza-Tesarik R, Mendoza N, López CC, et al. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study. Reprod Biomed Online. 2019. PMID: 31178369. doi:10.1016/j.rbmo.2019.03.215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。